National organization of high-value medical supplies joint procurement start crown vein bracket for the first batch of belt procurement varieties.

Pharmaceutical Network September 15th, 14th, the State Health Security Administration, together with the relevant departments in Tianjin, organized a national organization of high-value medical supplies centralized procurement and use of the work of the start-up meeting, the crown stent is the first batch of with volume procurement varieties.
The Joint Procurement Office for High-Value Medical Supplies was established in Tianjin today, and the Tianjin Pharmaceutical Purchasing Center specifically undertakes the daily work of the Joint Procurement Office for High-Value Medical Supplies organized by the State Organization.
crown vein bracket is the first batch of volume procurement varieties.
data show that from 2009 to 2019, The interventional treatment of coronary heart disease in China developed rapidly, with the number of cases per year growing from 230,000 to more than 1 million, with an annual growth rate of 10% to 20%.
, the number of surgical stents used is about 1.5, which is basically the same level as abroad.
, it is calculated that in 2019 the country will use about 1.5 million crown brackets, the cost of about 15 billion, accounting for one-tenth of the total cost of high-value consumables in the country.
prices and use of selected products for centralized procurement of crown stents are expected to be implemented by January 2021.
Tiejun, Deputy Director of The Tianjin Municipal Health Insurance Bureau: In September, we organized the various alliance medical institutions to complete the statistical work on the overall collection of historical reports and future demand.
in October we will publish the collection documents for the community, and in November we will determine the final results in conjunction with the prices declared by the enterprises.
will be fully implemented on January 1 next year, the price and use of selected products provided.
, according to the State Health Insurance Administration, the national medical supplies market size of 320 billion yuan, of which 150 billion high-value supplies.
After more than two years of efforts, centralized procurement of drugs has entered the normal, high-value medical supplies in the field of high prices and centralized procurement reform obviously lag behind, if high-value medical supplies do not reform and breakthrough, can not be the overall transformation of the pharmaceutical sector ecology.
Jinfu, Deputy Director of the State Administration of Health And Social Security: So this is the only way for China to develop to this point, in a sense, to high-quality development.
must cut off the impact of the original sales model on the development of China's industry, and really through cost competition, quality competition, innovation, to promote China's large-scale high-quality development.
.